Aug 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2025 Jun 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.44 3.00 11.73
(-18.6 pct) (-12.4 pct) (+9.9 pct)
Operating 117 mln 395 mln 953 mln
(-70.3 pct) (+64.6 pct) (+13.6 pct)
Recurring 31 mln 513 mln 844 mln
(-93.9 pct) (+48.7 pct) (+20.2 pct)
Net 9 mln 351 mln 711 mln
(-97.4 pct) (+106.0 pct) (+57.1 pct)
EPS 1.12 yen 43.25 yen 87.80 yen
Ann Div 9.00 yen 9.00 yen
-Q2 div NIL NIL
-Q4 div 9.00 yen 9.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T